BT6487 - you are getting your trials mixed up.
It was the FSGS Phase 2a result that shot the share price from 38c to a high of 77c which was then torn down by the DKD Phase 2 results.
On-going understanding of the positive FSGS Phase 2a was then lost in the 'noise' of the reaction to the DKD results just 6 weeks later. Illogically, the FSGS trial got tarnished with the same brush.
The March interim reading is ONLY to do with the so-far positive FSGS trial - not the so-far neutral DKD trial.
This confusion over the trials is why DXB has been such a great opportunity.
I expect an even bigger response with a positive outcome for Phase 3 than was experienced with the Phase 2a - partly because it is from a much lower base (than the 38c immediately prior to the Phase 2a results announcement).
BT6487 - you are getting your trials mixed up. It was the FSGS...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $197.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.3¢ | 33.5¢ | $3.801M | 10.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 378856 | 6 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
36.0¢ |
Change
0.025 ( 7.33 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 36.5¢ | 33.5¢ | 5557634 | ||
| Last updated 15.58pm 03/05/2024 ? | |||||
| DXB (ASX) Chart |